Interstitial Lung Disease and Obstructive Sleep Apnea
Recruiting
Observational Study
ILD OSA
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Dan Liu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Clinically, all patients with interstitial lung disease(ILD) were observed, and relevant clinical data were collected. Bronchoscopic specimens were collected according to the condition of the enrolled patients, and the rapid on site evaluation(ROSE) was evaluated, combined with the metagenomic next generation sequencing(mNGS) results of these patients. To observe the etiology and biological charac…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* over 18 years old and under 80 years old.
* Clinical diagnosis of interstitial lung disease or obstructive respiratory sleep apnea syndrome.
* Patient is conscious and capable of signing informed consent.
* The patient may wear a polysomnograph.
Exclusion criteria:
* maligna…
Contacts